Galderma Group N
🇨🇭XSWX.GALDSwitzerlandHealthcare
PriceCHF 163.00+0.90 (+0.56%)
Latest anomalies
Negative 1 detected in the last 120 days
- High: 1
- Medium: 0
- Low: 0
Volume: a spike above the 20-day average
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Switzerland
Identity
- Exchange
- SIX Swiss Exchange . XSWX
- Type
- Stock
- ISIN
- CH1335392721
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- Zug, Switzerland
- Website
- https://www.galderma.com
Market
- Shares outstanding
- 234.8M
- Market cap
- CHF 38.28B
Highlights
- Market cap
- CHF 38.06B
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- Not reported
- Gross margin
- Not reported
- Free cash flow
- Not reported
Latest news
News is not sourced for this exchange.
Business summary
Galderma Group N is a company in the healthcare sector, listed on SIX Swiss Exchange (Switzerland) under the ticker GALD. Its market capitalisation is CHF 38.28B, from 234.8M shares outstanding, as of . Across the 249 trading sessions to the shares traded between CHF 134.20 and CHF 188.25, and the last close of CHF 163.00 sits 53% of the way up that range. The company is headquartered in Zug, Switzerland.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.